cadazolid,
Cadazolid,
1025097-10-2,
ACT-179811,
UNII-2OEA2UN10Y,
2OEA2UN10Y,
1-Cyclopropyl-6-fluoro-7-[4-[2-fluoro-4-[5(R )-(hydroxymethyl)-2-oxooxazolidin-3-yl]phenoxymethyl]-4-hydroxypiperidin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid;1-Cyclopropyl-6-fluoro-7-[4-[2-fluoro-4-[5(R )-(hydroxymethyl)-2-oxooxazolidin-3-yl]phenoxymethyl]-4-hydroxypiperidin-1-yl]-4-oxo-1,4-dihydroquinoline-3-carboxylic acid,
Cadazolid [USAN:INN],
SCHEMBL541618,
Cadazolid (ACT-179811),
CHEMBL3707376,
DTXSID10145234,
BCP20623,
EX-A1438,
CS-6972,
DB11847,
SB18979,
1-Cyclopropyl-6-fluoro-7-(4-((2-fluoro-4-((R)-5-hydroxymethyl-2-oxooxazolidin-3-yl)phenoxy)methyl)-4-hydroxypiperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid,
HY-100436,
J3.437.086I,
(R)-1-cyclopropyl-6-fluoro-7-(4-((2-fluoro-4-(5-(hydroxymethyl)-2-oxooxazolidin-3-yl)phenoxy)methyl)-4-hydroxypiperidin-1-yl)-4-oxo-1,4-dihydroquinoline-3-carboxylic acid,
JJH,
Cadazolid [INN],